Financial Wire

EMEA Natural Gas Update: Futures Rise Despite Reports of Ceasefire Extension Between the US, Iran

-- European natural gas futures were up on Thursday, amid reports of the US and Iran considering an extension to the current ceasefire by two more weeks, to allow more time to negotiate a peace agreement.

The front-month Dutch TTF contract rose 1.96% to 42.21 euros ($49.72) per megawatt-hour, while UK NBP futures rose 1.91% to 105.65 British pence ($1.42) per therm.

The ceasefire, which was set to end on the coming Tuesday, could be extended further, as negotiators on both sides plan to hold technical talks, which include the reopening of the Strait of Hormuz and Iran's nuclear enrichment, according to a Bloomberg report, citing a person familiar with the matter.

Meanwhile, the US Central Command has released audio recordings of US Naval vessels enforcing the blockade against Iran, with commercial ships being threatened with "interdiction and seizure" for transiting to and from Iranian ports.

Transit through the Strait, however, inched higher, with 19 vessels passing through it over the past 24 hours, according to the Hormuz Strait Monitor.

This is still significantly below the typical daily average of 138 ships per day, according to the UK's Joint Maritime Information Center.

As such, Daniel Hynes, a senior commodity strategist at ANZ, noted that traders remained mindful of the fact that "supplies remain severely constrained" with the Strait still being effectively closed, despite growing optimism regarding a potential peace deal.

He attributed the recent pullback in energy prices to the unwinding of "large net long positions recently accumulated by investment funds."

European gas inventories continued to see net injections, with storage still lower at 29.55% of capacity, compared to 35.97% during the corresponding period a year ago, according to Gas Infrastructure Europe.

相关文章

Asia

河北常山生化制药有限公司的血液稀释注射剂获吉尔吉斯斯坦批准

据周四提交深圳证券交易所的披露文件显示,吉尔吉斯斯坦药品监管机构已批准河北常山生化药业(深交所代码:300255)的肝素钠注射液上市。 文件指出,该药物用于治疗血栓或栓塞性疾病,具有抗凝血作用,可预防血栓形成。

$SHE:300255
Mining & Metals

铀矿特许权使用费在盘前交易中上涨6.6%,此前该公司同意以19亿美元收购Sweetwater Royalties。

Uranium Royalty (URC.TO, UROY) 周四宣布,已同意以19亿美元(含债务)的价格从Orion Resource Partners和安大略省教师养老金计划管理的基金手中收购Sweetwater Royalties,受此消息提振,该公司股价在纳斯达克盘前交易中上涨6.6%。 这家总部位于温哥华的公司表示,将把注册地迁至特拉华州以完成此次交易。Uranium Royalty将保留原有名称,并将此次变更称为“新URC”。现有股东将按1:1的比例获得新URC的股份,而Sweetwater的股东将获得价值8.13亿美元的新公司股份(每股作价3.64美元)和3.3亿美元现金,同时新URC还将承担Sweetwater的6.25亿美元债务。 这项交易将造就美国第二大土地所有者(不包括房地产投资信托基金),以及怀俄明州最大的土地所有者。交易完成后,该公司将控制85万英亩的地表权和450万英亩的矿产开采权,进一步扩大其在萨斯喀彻温省阿萨巴斯卡盆地、怀俄明州和纳米比亚的现有矿产资源组合。该公司表示,此次交易还将使铀矿资源公司(Uranium Royalty)成为美国最大的上市非贵金属矿产资源公司。 此次收购还将使该公司获得Sweetwater在怀俄明州的纯碱矿产资源组合。Sweetwater在怀俄明州已知钠租赁区拥有20万英亩的土地,用于开采这种用于生产玻璃、化学品和其他工业产品的工业矿物。 “我们欢迎这项变革性的合并,它将加速来自位于顶级司法管辖区怀俄明州的具有竞争力、可靠性高且寿命长的资产的近期现金流。我们对怀俄明州有着深厚的感情和熟悉程度。更重要的是,它为我们提供了强大的财务基础,使我们能够在核能历史性增长时期充分实现并扩大我们在铀矿领域的业务。全球铀市场正面临严重的初级供应缺口,预计这将推动未来几年大量的资本投资,”首席执行官斯科特·梅尔比在一份声明中表示。 该公司表示,将以现有现金和4000万美元的认购凭证为此次交易提供资金。 铀矿特许权使用费公司(Uranium Royalty)的股票在盘前交易中上涨0.23美元,至4.15美元。周三在多伦多证券交易所,该股收盘上涨0.25加元,至5.40加元。

$URC.TO$UROY
Asia

韩森制药的肺癌药物在中国获得突破性疗法认定

据周四在香港交易所发布的公告显示,韩森制药(HKG:3692)的注射用药物HS-20093(与阿德布雷利单抗联合使用)已获得中国国家药品监督管理局批准,成为突破性疗法指定药物。 该药物获批用于治疗局部晚期或转移性非小细胞肺癌。

$HKG:3692